AJANTPHARM.BOAJANTPHARM.BOBSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-45.0%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-45.0%/yr
vs +18.5%/yr prior
Acceleration
-63.5pp
Decelerating
Percentile
P50
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 7.83% |
| 2024 | -12.35% |
| 2023 | 15.99% |
| 2022 | 47.10% |
| 2021 | -15.39% |
| 2020 | -6.73% |
| 2019 | -5.49% |
| 2018 | 23.89% |
| 2017 | 41.19% |
| 2016 | 51.95% |